Patent Assignment
Reel/Frame 023826/0784
Change of Name
Recorded: 2010-01-19
Pages: 4
Assignor
SCHERING AKTIENGESELLSCHAFT
Executed: 2006-12-29
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, D-13353, GERMANY
Covered Properties
(10)
Pharmaceutical Composition for Use as a Contraceptive
Patent:
6,787,531 →
Application:
09/654,227 →
Drospirenone for hormone replacement therapy
Application:
09/757,688 →
Publication:
US 2002/0132801
Male Contraceptive Formulation Comprising Norethisterone
Cyclodextrin-Drospirenone Inclusion Complexes
Combination of Drospirenone and an Estrogen Sulphamate for Hrt
Cardiovascular Protection Using Anti-Aldosteronic Progestins
Transdermal Delivery of Hormones Without the Need of Penetration Enhancers
Stabilised Supersaturated Solids of Lipophilic Drugs
Molecular dispersions of drospirenone
Application:
11/076,034 →
Publication:
US 2005/0220825
Oral Solid Dosage Forms Containing a Low Dose of Estradiol
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Nov 28, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029373/0170 →
Previously Recorded Assignment (on 11/28/2012-029373/0170) Contained the English Language Translation of the Commercial Register. the German Version of the Commercial Register, English Translation and Translator Certificate Now Submitted.
Apr 29, 2014
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 032796/0029 →
Change of Name
Jul 25, 2014
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 033391/0576 →
Change of Name
Jul 25, 2014
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 033418/0647 →
Assignment of Assignor's Interest
Nov 22, 2019
From: BAYER INTELLECTUAL PROPERTY GMBH
To: LUYE PHARMA SWITZERLAND AG
Reel/Frame 051088/0904 →